Natalie Serkova
Concepts (676)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Spectroscopy | 35 | 2014 | 513 | 3.170 |
Why?
| Cyclosporine | 18 | 2012 | 175 | 2.800 |
Why?
| Immunosuppressive Agents | 21 | 2013 | 687 | 2.320 |
Why?
| Sirolimus | 17 | 2013 | 198 | 2.030 |
Why?
| Magnetic Resonance Imaging | 24 | 2020 | 3264 | 1.910 |
Why?
| Pyrimidines | 8 | 2017 | 388 | 1.410 |
Why?
| Piperazines | 6 | 2009 | 326 | 1.370 |
Why?
| Metabolomics | 11 | 2021 | 550 | 1.330 |
Why?
| Glucose | 14 | 2021 | 968 | 1.230 |
Why?
| Contrast Media | 6 | 2017 | 387 | 1.190 |
Why?
| Energy Metabolism | 13 | 2019 | 783 | 1.140 |
Why?
| Antineoplastic Agents | 15 | 2022 | 1990 | 1.140 |
Why?
| Brain | 13 | 2020 | 2540 | 1.130 |
Why?
| Biomarkers | 14 | 2019 | 3662 | 1.050 |
Why?
| Liver | 12 | 2020 | 1827 | 1.030 |
Why?
| Neoplasms | 14 | 2017 | 2235 | 1.020 |
Why?
| Drug Resistance, Neoplasm | 6 | 2017 | 673 | 0.990 |
Why?
| Animals | 95 | 2023 | 34133 | 0.940 |
Why?
| Neoplasms, Experimental | 3 | 2020 | 162 | 0.920 |
Why?
| Reperfusion Injury | 11 | 2014 | 279 | 0.810 |
Why?
| Biomarkers, Tumor | 10 | 2020 | 1076 | 0.760 |
Why?
| Multimodal Imaging | 1 | 2020 | 102 | 0.740 |
Why?
| Proton Magnetic Resonance Spectroscopy | 2 | 2019 | 22 | 0.730 |
Why?
| Protein Kinase Inhibitors | 10 | 2018 | 833 | 0.710 |
Why?
| Rats | 29 | 2015 | 5426 | 0.700 |
Why?
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 | 2014 | 93 | 0.690 |
Why?
| Ferrosoferric Oxide | 3 | 2019 | 26 | 0.680 |
Why?
| Metabolome | 5 | 2019 | 299 | 0.660 |
Why?
| Cell Line, Tumor | 25 | 2023 | 2904 | 0.650 |
Why?
| Nanoparticles | 4 | 2017 | 329 | 0.630 |
Why?
| Ischemic Preconditioning | 2 | 2009 | 29 | 0.630 |
Why?
| Hypoxia | 6 | 2015 | 1003 | 0.570 |
Why?
| Fusion Proteins, bcr-abl | 5 | 2015 | 61 | 0.560 |
Why?
| Phospholipids | 7 | 2010 | 211 | 0.560 |
Why?
| Everolimus | 12 | 2013 | 64 | 0.540 |
Why?
| Aging | 5 | 2020 | 1694 | 0.540 |
Why?
| Rats, Wistar | 11 | 2010 | 405 | 0.540 |
Why?
| Mice | 45 | 2023 | 15888 | 0.530 |
Why?
| Glutathione | 9 | 2023 | 327 | 0.520 |
Why?
| Body Fluids | 5 | 2019 | 66 | 0.510 |
Why?
| Inositol | 4 | 2021 | 26 | 0.510 |
Why?
| Glutamine | 6 | 2013 | 89 | 0.500 |
Why?
| Epilepsy, Post-Traumatic | 1 | 2013 | 2 | 0.490 |
Why?
| Organ Specificity | 4 | 2013 | 287 | 0.480 |
Why?
| Brain Injuries | 3 | 2014 | 488 | 0.470 |
Why?
| Nephritis | 1 | 2013 | 32 | 0.470 |
Why?
| Mitochondria | 7 | 2014 | 809 | 0.470 |
Why?
| Positron-Emission Tomography | 10 | 2020 | 308 | 0.460 |
Why?
| Lupus Nephritis | 2 | 2011 | 56 | 0.460 |
Why?
| Imatinib Mesylate | 7 | 2014 | 63 | 0.440 |
Why?
| Leukemia | 2 | 2018 | 209 | 0.430 |
Why?
| Disease Models, Animal | 16 | 2023 | 3799 | 0.420 |
Why?
| Apoptosis | 14 | 2022 | 2532 | 0.420 |
Why?
| Placenta | 3 | 2009 | 648 | 0.410 |
Why?
| Metabolism | 3 | 2017 | 40 | 0.410 |
Why?
| Humans | 71 | 2023 | 122796 | 0.400 |
Why?
| Reactive Oxygen Species | 5 | 2013 | 592 | 0.400 |
Why?
| Drug Monitoring | 3 | 2013 | 189 | 0.400 |
Why?
| Oxidative Stress | 5 | 2010 | 1204 | 0.400 |
Why?
| Benzamides | 6 | 2009 | 175 | 0.390 |
Why?
| Kidney | 7 | 2023 | 1355 | 0.390 |
Why?
| Cerebellar Neoplasms | 2 | 2023 | 135 | 0.390 |
Why?
| Time Factors | 12 | 2013 | 6682 | 0.380 |
Why?
| Seizures | 1 | 2013 | 360 | 0.380 |
Why?
| Medulloblastoma | 2 | 2023 | 177 | 0.380 |
Why?
| Astrocytes | 4 | 2015 | 176 | 0.380 |
Why?
| Liver Diseases | 2 | 2010 | 325 | 0.360 |
Why?
| Kidney Diseases | 2 | 2020 | 446 | 0.360 |
Why?
| Diagnostic Imaging | 2 | 2011 | 310 | 0.360 |
Why?
| Molecular Targeted Therapy | 2 | 2017 | 361 | 0.350 |
Why?
| Molecular Probes | 1 | 2009 | 31 | 0.350 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2017 | 252 | 0.350 |
Why?
| Cell Proliferation | 13 | 2022 | 2328 | 0.350 |
Why?
| Glucose Transporter Type 1 | 1 | 2009 | 42 | 0.340 |
Why?
| Prostatic Neoplasms | 5 | 2016 | 964 | 0.330 |
Why?
| Lactic Acid | 7 | 2013 | 283 | 0.330 |
Why?
| Silymarin | 4 | 2016 | 194 | 0.330 |
Why?
| Complement C3b | 2 | 2023 | 32 | 0.330 |
Why?
| Spermine | 1 | 2008 | 28 | 0.330 |
Why?
| Liver Transplantation | 2 | 2007 | 929 | 0.330 |
Why?
| K562 Cells | 4 | 2009 | 75 | 0.320 |
Why?
| Citric Acid | 1 | 2008 | 35 | 0.320 |
Why?
| Adaptation, Physiological | 2 | 2009 | 510 | 0.320 |
Why?
| Xenograft Model Antitumor Assays | 9 | 2019 | 747 | 0.320 |
Why?
| Graft Rejection | 5 | 2010 | 556 | 0.310 |
Why?
| Drug Design | 2 | 2007 | 163 | 0.310 |
Why?
| Hibernation | 2 | 2014 | 77 | 0.310 |
Why?
| Tomography, X-Ray Computed | 3 | 2020 | 2500 | 0.310 |
Why?
| Kidney Transplantation | 4 | 2010 | 584 | 0.300 |
Why?
| Head and Neck Neoplasms | 3 | 2019 | 475 | 0.300 |
Why?
| Altitude | 3 | 2009 | 425 | 0.300 |
Why?
| Prostate | 1 | 2008 | 166 | 0.300 |
Why?
| Creatine | 3 | 2021 | 56 | 0.290 |
Why?
| Choline | 2 | 2009 | 115 | 0.290 |
Why?
| Colorectal Neoplasms | 4 | 2018 | 646 | 0.290 |
Why?
| Liver Failure | 1 | 2007 | 94 | 0.290 |
Why?
| Dietary Supplements | 3 | 2023 | 473 | 0.280 |
Why?
| Pneumonia | 2 | 2011 | 605 | 0.280 |
Why?
| Drug Therapy | 1 | 2006 | 75 | 0.280 |
Why?
| Male | 45 | 2022 | 59639 | 0.280 |
Why?
| Brain Neoplasms | 4 | 2020 | 1016 | 0.270 |
Why?
| Adenosine Triphosphate | 5 | 2009 | 456 | 0.270 |
Why?
| Signal Transduction | 11 | 2019 | 4902 | 0.270 |
Why?
| Glioma | 3 | 2020 | 300 | 0.270 |
Why?
| Brain Injuries, Traumatic | 2 | 2023 | 325 | 0.270 |
Why?
| Interleukin-1beta | 1 | 2008 | 383 | 0.270 |
Why?
| Sex Characteristics | 1 | 2010 | 690 | 0.270 |
Why?
| fms-Like Tyrosine Kinase 3 | 2 | 2016 | 43 | 0.270 |
Why?
| Blotting, Western | 6 | 2019 | 1225 | 0.260 |
Why?
| Neovascularization, Pathologic | 4 | 2018 | 292 | 0.260 |
Why?
| Macrolides | 2 | 2013 | 66 | 0.260 |
Why?
| Protein Kinases | 2 | 2004 | 325 | 0.250 |
Why?
| Carcinoma, Hepatocellular | 2 | 2020 | 231 | 0.250 |
Why?
| Organ Transplantation | 2 | 2004 | 165 | 0.250 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2022 | 466 | 0.250 |
Why?
| Protein-Tyrosine Kinases | 3 | 2014 | 442 | 0.250 |
Why?
| Neurotoxicity Syndromes | 1 | 2004 | 16 | 0.250 |
Why?
| Sepsis | 4 | 2013 | 546 | 0.240 |
Why?
| Glycolysis | 4 | 2010 | 227 | 0.240 |
Why?
| Obesity | 3 | 2006 | 2786 | 0.240 |
Why?
| Cell Transformation, Neoplastic | 3 | 2015 | 320 | 0.240 |
Why?
| Rats, Sprague-Dawley | 9 | 2015 | 2501 | 0.240 |
Why?
| Drug Interactions | 5 | 2012 | 356 | 0.240 |
Why?
| Myocardium | 2 | 2013 | 982 | 0.240 |
Why?
| Lung Transplantation | 3 | 2000 | 273 | 0.230 |
Why?
| Chromatography, High Pressure Liquid | 4 | 2009 | 493 | 0.230 |
Why?
| Autolysis | 1 | 2003 | 3 | 0.230 |
Why?
| Myocardial Reperfusion Injury | 1 | 2003 | 107 | 0.230 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2008 | 1181 | 0.220 |
Why?
| Deoxycytidine | 2 | 2017 | 141 | 0.220 |
Why?
| Gene Expression Regulation, Neoplastic | 5 | 2020 | 1183 | 0.220 |
Why?
| Fatty Liver | 1 | 2005 | 254 | 0.220 |
Why?
| Glomerulonephritis | 1 | 2023 | 61 | 0.220 |
Why?
| Phosphates | 2 | 2001 | 170 | 0.220 |
Why?
| Autophagy | 2 | 2018 | 321 | 0.210 |
Why?
| Colonic Neoplasms | 3 | 2013 | 230 | 0.210 |
Why?
| Carbon Isotopes | 3 | 2009 | 116 | 0.210 |
Why?
| In Vitro Techniques | 5 | 2016 | 1130 | 0.210 |
Why?
| Antineoplastic Agents, Phytogenic | 2 | 2013 | 184 | 0.210 |
Why?
| Specimen Handling | 1 | 2003 | 169 | 0.200 |
Why?
| Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 65 | 0.200 |
Why?
| Blood-Brain Barrier | 2 | 2013 | 107 | 0.200 |
Why?
| Mice, Nude | 8 | 2016 | 668 | 0.200 |
Why?
| Chemoradiotherapy | 2 | 2019 | 201 | 0.200 |
Why?
| Hydroxamic Acids | 2 | 2011 | 80 | 0.200 |
Why?
| Photoacoustic Techniques | 1 | 2020 | 4 | 0.200 |
Why?
| Image Processing, Computer-Assisted | 3 | 2019 | 739 | 0.200 |
Why?
| Radiation Tolerance | 1 | 2022 | 98 | 0.200 |
Why?
| Tendinopathy | 1 | 2021 | 34 | 0.200 |
Why?
| Rhabdoid Tumor | 1 | 2022 | 80 | 0.200 |
Why?
| Magnetite Nanoparticles | 2 | 2011 | 28 | 0.200 |
Why?
| Lung | 8 | 2018 | 3830 | 0.200 |
Why?
| Gene Expression Regulation | 4 | 2019 | 2491 | 0.190 |
Why?
| Dose-Response Relationship, Drug | 8 | 2012 | 1981 | 0.190 |
Why?
| TOR Serine-Threonine Kinases | 5 | 2018 | 377 | 0.190 |
Why?
| Anticarcinogenic Agents | 2 | 2011 | 70 | 0.190 |
Why?
| Heat-Shock Proteins | 3 | 2006 | 129 | 0.190 |
Why?
| Perfusion | 3 | 2009 | 160 | 0.190 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 2020 | 108 | 0.190 |
Why?
| Mass Spectrometry | 4 | 2011 | 686 | 0.190 |
Why?
| Mammary Glands, Animal | 2 | 2014 | 123 | 0.190 |
Why?
| Anterior Cruciate Ligament Injuries | 1 | 2022 | 148 | 0.180 |
Why?
| Camptothecin | 2 | 2013 | 100 | 0.180 |
Why?
| Insulin Resistance | 2 | 2019 | 1192 | 0.180 |
Why?
| Osteoarthritis | 1 | 2022 | 184 | 0.180 |
Why?
| Transcriptional Elongation Factors | 1 | 2020 | 33 | 0.180 |
Why?
| Polycomb Repressive Complex 1 | 1 | 2020 | 51 | 0.180 |
Why?
| Particle Accelerators | 1 | 2019 | 9 | 0.180 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2014 | 1402 | 0.180 |
Why?
| Electromagnetic Phenomena | 1 | 2019 | 23 | 0.180 |
Why?
| Scavenger Receptors, Class A | 1 | 2019 | 9 | 0.180 |
Why?
| Complement Factor H | 1 | 2020 | 62 | 0.180 |
Why?
| Lactation | 2 | 2014 | 162 | 0.180 |
Why?
| Histone Deacetylase Inhibitors | 2 | 2011 | 202 | 0.180 |
Why?
| Chromosomes, Human, Pair 1 | 1 | 2019 | 75 | 0.180 |
Why?
| Brain Chemistry | 1 | 2000 | 120 | 0.180 |
Why?
| Heart | 1 | 2003 | 649 | 0.180 |
Why?
| Fatty Acids | 2 | 2015 | 410 | 0.180 |
Why?
| Endoplasmic Reticulum Stress | 3 | 2014 | 97 | 0.180 |
Why?
| DNA Repair | 1 | 2021 | 203 | 0.170 |
Why?
| Infratentorial Neoplasms | 1 | 2019 | 51 | 0.170 |
Why?
| Macrophages, Peritoneal | 1 | 2019 | 97 | 0.170 |
Why?
| Proto-Oncogene Proteins c-myc | 2 | 2021 | 122 | 0.170 |
Why?
| Precursor Cells, B-Lymphoid | 2 | 2017 | 35 | 0.170 |
Why?
| Fluorodeoxyglucose F18 | 2 | 2021 | 138 | 0.170 |
Why?
| Tumor Microenvironment | 2 | 2019 | 457 | 0.170 |
Why?
| Receptor, EphB4 | 1 | 2019 | 29 | 0.170 |
Why?
| Ephrin-B2 | 1 | 2019 | 42 | 0.170 |
Why?
| Lipogenesis | 2 | 2016 | 66 | 0.170 |
Why?
| Whey Proteins | 1 | 2018 | 5 | 0.170 |
Why?
| Angiogenesis Inhibitors | 2 | 2011 | 223 | 0.170 |
Why?
| Phosphocreatine | 3 | 2004 | 38 | 0.160 |
Why?
| Smad4 Protein | 1 | 2018 | 38 | 0.160 |
Why?
| Neoplasm Proteins | 2 | 2020 | 415 | 0.160 |
Why?
| Glucose Clamp Technique | 1 | 2019 | 195 | 0.160 |
Why?
| Histones | 2 | 2020 | 562 | 0.160 |
Why?
| Salivary Gland Neoplasms | 1 | 2018 | 32 | 0.160 |
Why?
| Tracheal Stenosis | 1 | 2018 | 23 | 0.160 |
Why?
| Anilides | 1 | 2018 | 69 | 0.160 |
Why?
| Polyenes | 1 | 1997 | 8 | 0.160 |
Why?
| Proto-Oncogene Proteins p21(ras) | 3 | 2013 | 243 | 0.160 |
Why?
| Liver Neoplasms | 2 | 2020 | 546 | 0.160 |
Why?
| Female | 28 | 2022 | 63629 | 0.160 |
Why?
| Rats, Zucker | 3 | 2006 | 34 | 0.160 |
Why?
| Mucin-1 | 1 | 2017 | 18 | 0.160 |
Why?
| Ependymoma | 1 | 2019 | 174 | 0.160 |
Why?
| Fibroblasts | 2 | 2016 | 846 | 0.150 |
Why?
| Macrophages | 3 | 2019 | 1334 | 0.150 |
Why?
| Neuroprotective Agents | 1 | 2018 | 110 | 0.150 |
Why?
| Kinetics | 3 | 2009 | 1658 | 0.150 |
Why?
| Folic Acid Deficiency | 1 | 2017 | 49 | 0.150 |
Why?
| Acute Lung Injury | 2 | 2011 | 313 | 0.150 |
Why?
| Cells, Cultured | 6 | 2019 | 4162 | 0.150 |
Why?
| PTEN Phosphohydrolase | 1 | 2018 | 149 | 0.150 |
Why?
| Lactates | 3 | 2006 | 87 | 0.150 |
Why?
| Drug Synergism | 5 | 2013 | 346 | 0.150 |
Why?
| Pancreatic Neoplasms | 2 | 2017 | 803 | 0.150 |
Why?
| Adenosine Diphosphate | 2 | 2009 | 89 | 0.150 |
Why?
| Blood Glucose | 4 | 2019 | 1957 | 0.150 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 64 | 0.140 |
Why?
| Quinazolines | 2 | 2008 | 243 | 0.140 |
Why?
| Glucosephosphate Dehydrogenase | 1 | 2016 | 42 | 0.140 |
Why?
| Tissue Extracts | 2 | 2009 | 21 | 0.140 |
Why?
| Heme Oxygenase (Decyclizing) | 2 | 2013 | 17 | 0.140 |
Why?
| Gene Expression Regulation, Leukemic | 1 | 2016 | 49 | 0.140 |
Why?
| Hematopoiesis | 1 | 2017 | 179 | 0.140 |
Why?
| Folic Acid | 1 | 2017 | 165 | 0.140 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2013 | 90 | 0.140 |
Why?
| Pyrazoles | 2 | 2010 | 366 | 0.140 |
Why?
| Inflammation Mediators | 1 | 2019 | 515 | 0.140 |
Why?
| Brain Concussion | 1 | 2023 | 470 | 0.140 |
Why?
| Alcohol Oxidoreductases | 1 | 2016 | 57 | 0.140 |
Why?
| Nuclear Magnetic Resonance, Biomolecular | 4 | 2011 | 241 | 0.140 |
Why?
| Transcription Factors | 5 | 2014 | 1616 | 0.140 |
Why?
| Flow Cytometry | 2 | 2010 | 1128 | 0.140 |
Why?
| Lipid Peroxidation | 3 | 2006 | 151 | 0.140 |
Why?
| Creatinine | 4 | 2005 | 510 | 0.140 |
Why?
| Neuroglia | 1 | 1996 | 153 | 0.140 |
Why?
| Familial Primary Pulmonary Hypertension | 1 | 2016 | 202 | 0.140 |
Why?
| Lipid Metabolism | 4 | 2019 | 482 | 0.130 |
Why?
| Hypothermia, Induced | 2 | 2006 | 69 | 0.130 |
Why?
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 191 | 0.130 |
Why?
| Methylamines | 2 | 2005 | 30 | 0.130 |
Why?
| Paracrine Communication | 1 | 2015 | 60 | 0.130 |
Why?
| Oligomycins | 1 | 2014 | 8 | 0.130 |
Why?
| Indoles | 2 | 2015 | 318 | 0.130 |
Why?
| Nuclear Proteins | 2 | 2023 | 618 | 0.130 |
Why?
| Radiography | 2 | 2008 | 888 | 0.130 |
Why?
| Mitochondrial Proton-Translocating ATPases | 1 | 2014 | 19 | 0.130 |
Why?
| Homeostasis | 1 | 2018 | 596 | 0.130 |
Why?
| Proto-Oncogene Proteins c-akt | 3 | 2018 | 433 | 0.130 |
Why?
| Pentacyclic Triterpenes | 1 | 2014 | 14 | 0.130 |
Why?
| Pyridines | 1 | 2018 | 440 | 0.130 |
Why?
| Fatty Acids, Unsaturated | 2 | 2005 | 87 | 0.130 |
Why?
| Ferric Compounds | 1 | 2014 | 39 | 0.130 |
Why?
| Fatty Acid Synthase, Type I | 1 | 2014 | 5 | 0.120 |
Why?
| ras Proteins | 2 | 2013 | 142 | 0.120 |
Why?
| Rats, Inbred Lew | 4 | 2010 | 87 | 0.120 |
Why?
| Models, Animal | 2 | 2009 | 373 | 0.120 |
Why?
| Convulsants | 1 | 2013 | 6 | 0.120 |
Why?
| Lipoxygenase Inhibitors | 1 | 2014 | 39 | 0.120 |
Why?
| Leukotrienes | 1 | 2014 | 34 | 0.120 |
Why?
| Hypertension, Pulmonary | 2 | 2016 | 1900 | 0.120 |
Why?
| Kainic Acid | 1 | 2013 | 31 | 0.120 |
Why?
| Dextrans | 2 | 2014 | 77 | 0.120 |
Why?
| Fetal Growth Retardation | 1 | 2019 | 473 | 0.120 |
Why?
| NAD | 2 | 2004 | 68 | 0.120 |
Why?
| Propranolol | 1 | 2013 | 52 | 0.120 |
Why?
| Prognosis | 4 | 2017 | 3563 | 0.120 |
Why?
| Urothelium | 1 | 2013 | 33 | 0.120 |
Why?
| Brain Edema | 1 | 2013 | 63 | 0.120 |
Why?
| Azoxymethane | 1 | 2013 | 17 | 0.120 |
Why?
| Unfolded Protein Response | 1 | 2013 | 48 | 0.120 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 95 | 0.110 |
Why?
| Mice, Inbred BALB C | 4 | 2019 | 1245 | 0.110 |
Why?
| Cell Survival | 4 | 2016 | 1075 | 0.110 |
Why?
| Triple Negative Breast Neoplasms | 1 | 2015 | 164 | 0.110 |
Why?
| Insulin | 3 | 2019 | 2180 | 0.110 |
Why?
| Grape Seed Extract | 1 | 2013 | 42 | 0.110 |
Why?
| Pregnancy | 6 | 2019 | 5854 | 0.110 |
Why?
| Estrogens | 1 | 2015 | 325 | 0.110 |
Why?
| Phosphorylation | 3 | 2013 | 1733 | 0.110 |
Why?
| Phytic Acid | 1 | 2012 | 46 | 0.110 |
Why?
| Equipment Design | 2 | 2019 | 533 | 0.110 |
Why?
| Feasibility Studies | 2 | 2019 | 780 | 0.110 |
Why?
| Tumor Cells, Cultured | 3 | 2019 | 904 | 0.110 |
Why?
| Receptors, Vascular Endothelial Growth Factor | 2 | 2015 | 105 | 0.110 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2019 | 1003 | 0.110 |
Why?
| Severity of Illness Index | 2 | 2013 | 2784 | 0.110 |
Why?
| Thiophenes | 1 | 2013 | 108 | 0.110 |
Why?
| Metabolic Diseases | 1 | 2013 | 104 | 0.110 |
Why?
| DNA-Binding Proteins | 3 | 2016 | 1384 | 0.110 |
Why?
| Reference Values | 3 | 2019 | 789 | 0.110 |
Why?
| Quinolines | 1 | 2013 | 127 | 0.110 |
Why?
| Image Enhancement | 2 | 2010 | 185 | 0.100 |
Why?
| Radionuclide Imaging | 1 | 2012 | 134 | 0.100 |
Why?
| Shock, Hemorrhagic | 1 | 2014 | 213 | 0.100 |
Why?
| Glioblastoma | 1 | 2014 | 262 | 0.100 |
Why?
| Sarcoma | 1 | 2013 | 138 | 0.100 |
Why?
| Mice, Transgenic | 6 | 2015 | 2079 | 0.100 |
Why?
| Isotope Labeling | 1 | 2012 | 76 | 0.100 |
Why?
| Treatment Outcome | 8 | 2016 | 9692 | 0.100 |
Why?
| Temperature | 3 | 2014 | 631 | 0.100 |
Why?
| HSP70 Heat-Shock Proteins | 3 | 2010 | 74 | 0.100 |
Why?
| Electroencephalography | 1 | 2013 | 408 | 0.100 |
Why?
| Tandem Mass Spectrometry | 2 | 2014 | 423 | 0.100 |
Why?
| Urinary Bladder | 1 | 2013 | 180 | 0.100 |
Why?
| Calcineurin | 1 | 2012 | 96 | 0.100 |
Why?
| Proto-Oncogene Proteins | 2 | 2013 | 646 | 0.100 |
Why?
| Reproducibility of Results | 5 | 2019 | 2977 | 0.100 |
Why?
| Adult | 10 | 2013 | 32385 | 0.100 |
Why?
| Antibodies, Monoclonal | 3 | 2023 | 1306 | 0.100 |
Why?
| Proteasome Inhibitors | 1 | 2011 | 46 | 0.100 |
Why?
| Adrenergic beta-Antagonists | 1 | 2013 | 334 | 0.100 |
Why?
| Tissue Distribution | 2 | 2003 | 339 | 0.100 |
Why?
| Mice, Inbred NOD | 3 | 2019 | 588 | 0.100 |
Why?
| Boronic Acids | 1 | 2011 | 43 | 0.100 |
Why?
| Tacrolimus | 1 | 2012 | 154 | 0.100 |
Why?
| Nucleotides | 2 | 2017 | 114 | 0.100 |
Why?
| Benzimidazoles | 1 | 2011 | 142 | 0.100 |
Why?
| Sciuridae | 2 | 2014 | 145 | 0.100 |
Why?
| Models, Biological | 5 | 2013 | 1756 | 0.100 |
Why?
| Pyrazines | 1 | 2011 | 79 | 0.090 |
Why?
| Phosphatidylinositol 3-Kinases | 3 | 2018 | 358 | 0.090 |
Why?
| Hydroxybutyrates | 2 | 2010 | 11 | 0.090 |
Why?
| Complement C3-C5 Convertases | 1 | 2010 | 19 | 0.090 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2010 | 171 | 0.090 |
Why?
| Protease Inhibitors | 1 | 2011 | 106 | 0.090 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2016 | 534 | 0.090 |
Why?
| Cricetulus | 1 | 2010 | 100 | 0.090 |
Why?
| CHO Cells | 1 | 2010 | 145 | 0.090 |
Why?
| TRPP Cation Channels | 1 | 2010 | 62 | 0.090 |
Why?
| Mice, Knockout | 5 | 2020 | 2737 | 0.090 |
Why?
| Heart Ventricles | 1 | 2015 | 741 | 0.090 |
Why?
| Cricetinae | 1 | 2010 | 269 | 0.090 |
Why?
| Fatty Acids, Monounsaturated | 2 | 2010 | 48 | 0.090 |
Why?
| Epigenomics | 2 | 2020 | 108 | 0.090 |
Why?
| Drug Delivery Systems | 2 | 2017 | 312 | 0.090 |
Why?
| Ribose | 1 | 2009 | 18 | 0.090 |
Why?
| Neoplasm Transplantation | 3 | 2019 | 248 | 0.090 |
Why?
| ErbB Receptors | 2 | 2015 | 571 | 0.090 |
Why?
| Cognition Disorders | 1 | 2014 | 547 | 0.090 |
Why?
| Cysts | 1 | 2010 | 94 | 0.090 |
Why?
| Intestine, Small | 1 | 2010 | 135 | 0.090 |
Why?
| Dinoprost | 1 | 2009 | 32 | 0.090 |
Why?
| Deoxyglucose | 1 | 2009 | 48 | 0.090 |
Why?
| Cell Extracts | 1 | 2009 | 17 | 0.090 |
Why?
| Alanine | 2 | 2013 | 103 | 0.090 |
Why?
| Percussion | 1 | 2008 | 3 | 0.090 |
Why?
| RNA, Neoplasm | 1 | 2009 | 79 | 0.090 |
Why?
| Analysis of Variance | 2 | 2010 | 1329 | 0.090 |
Why?
| History, 21st Century | 1 | 2009 | 177 | 0.080 |
Why?
| Gas Chromatography-Mass Spectrometry | 1 | 2009 | 139 | 0.080 |
Why?
| Sulfonamides | 2 | 2011 | 455 | 0.080 |
Why?
| Mutation | 3 | 2020 | 3493 | 0.080 |
Why?
| Surgical Equipment | 1 | 2008 | 13 | 0.080 |
Why?
| Systems Biology | 1 | 2009 | 59 | 0.080 |
Why?
| Oxidation-Reduction | 3 | 2016 | 931 | 0.080 |
Why?
| History, 20th Century | 1 | 2009 | 288 | 0.080 |
Why?
| Receptor, ErbB-3 | 1 | 2008 | 42 | 0.080 |
Why?
| Macaca fascicularis | 4 | 2000 | 53 | 0.080 |
Why?
| Neurons | 1 | 1996 | 1345 | 0.080 |
Why?
| Complement C3d | 2 | 2023 | 60 | 0.080 |
Why?
| Oxygen | 2 | 2010 | 887 | 0.080 |
Why?
| Fluorouracil | 1 | 2008 | 160 | 0.080 |
Why?
| Body Weight | 4 | 2012 | 958 | 0.080 |
Why?
| Critical Illness | 2 | 2011 | 728 | 0.080 |
Why?
| Lymphocytes | 1 | 2009 | 360 | 0.080 |
Why?
| Protein Transport | 1 | 2009 | 418 | 0.080 |
Why?
| Disease Progression | 5 | 2018 | 2546 | 0.080 |
Why?
| Area Under Curve | 1 | 2008 | 303 | 0.080 |
Why?
| Triglycerides | 2 | 2010 | 527 | 0.080 |
Why?
| Mice, Inbred C57BL | 5 | 2018 | 5020 | 0.080 |
Why?
| Oxidative Phosphorylation | 2 | 2005 | 160 | 0.070 |
Why?
| Heart-Assist Devices | 1 | 2013 | 487 | 0.070 |
Why?
| DNA | 2 | 2009 | 1401 | 0.070 |
Why?
| X-Ray Microtomography | 2 | 2021 | 74 | 0.070 |
Why?
| Heterografts | 2 | 2019 | 132 | 0.070 |
Why?
| Tritium | 1 | 2006 | 71 | 0.070 |
Why?
| Polycystic Kidney, Autosomal Dominant | 1 | 2010 | 209 | 0.070 |
Why?
| Medical Oncology | 1 | 2009 | 231 | 0.070 |
Why?
| Chromatin | 2 | 2020 | 450 | 0.070 |
Why?
| ROC Curve | 1 | 2008 | 494 | 0.070 |
Why?
| Body Temperature | 1 | 2007 | 219 | 0.070 |
Why?
| Age Factors | 2 | 2011 | 3114 | 0.070 |
Why?
| MicroRNAs | 1 | 2013 | 661 | 0.070 |
Why?
| Leukocytes, Mononuclear | 1 | 2009 | 514 | 0.070 |
Why?
| Piperidines | 1 | 2007 | 169 | 0.070 |
Why?
| Maximum Tolerated Dose | 3 | 2013 | 186 | 0.070 |
Why?
| Heat-Shock Response | 1 | 2006 | 60 | 0.070 |
Why?
| Up-Regulation | 2 | 2006 | 891 | 0.070 |
Why?
| Nitrogen | 1 | 2007 | 155 | 0.070 |
Why?
| Receptor, ErbB-2 | 1 | 2008 | 321 | 0.070 |
Why?
| Alcohol Drinking | 1 | 2012 | 668 | 0.070 |
Why?
| Liver Failure, Acute | 1 | 2006 | 68 | 0.070 |
Why?
| Deuterium | 1 | 2005 | 77 | 0.070 |
Why?
| Survival Rate | 3 | 2019 | 1810 | 0.070 |
Why?
| Lung Injury | 1 | 2008 | 215 | 0.070 |
Why?
| Allantoin | 1 | 2005 | 3 | 0.070 |
Why?
| Betaine | 1 | 2005 | 64 | 0.070 |
Why?
| Glutamic Acid | 2 | 2010 | 227 | 0.070 |
Why?
| Methionine | 1 | 2005 | 147 | 0.060 |
Why?
| Seasons | 1 | 2007 | 468 | 0.060 |
Why?
| Reference Standards | 2 | 2019 | 177 | 0.060 |
Why?
| Glutamates | 1 | 2004 | 61 | 0.060 |
Why?
| Inflammation | 3 | 2015 | 2598 | 0.060 |
Why?
| Mitochondrial Encephalomyopathies | 1 | 2004 | 8 | 0.060 |
Why?
| Lipids | 2 | 2021 | 614 | 0.060 |
Why?
| Aged | 5 | 2013 | 20495 | 0.060 |
Why?
| Hot Temperature | 1 | 2006 | 345 | 0.060 |
Why?
| Heart Rate | 2 | 2009 | 756 | 0.060 |
Why?
| Free Radical Scavengers | 1 | 2004 | 90 | 0.060 |
Why?
| Biological Transport | 2 | 2015 | 392 | 0.060 |
Why?
| Dacarbazine | 2 | 2014 | 102 | 0.060 |
Why?
| Cholesterol | 1 | 2005 | 380 | 0.060 |
Why?
| HSP72 Heat-Shock Proteins | 1 | 2003 | 29 | 0.060 |
Why?
| Hypoxia-Ischemia, Brain | 1 | 2004 | 27 | 0.060 |
Why?
| Gene Expression Profiling | 3 | 2019 | 1625 | 0.060 |
Why?
| Calcineurin Inhibitors | 1 | 2003 | 62 | 0.060 |
Why?
| Coronary Circulation | 1 | 2003 | 121 | 0.060 |
Why?
| Injections, Intravenous | 1 | 2003 | 217 | 0.060 |
Why?
| Proteins | 1 | 2009 | 953 | 0.060 |
Why?
| Cardiac Output | 1 | 2003 | 154 | 0.060 |
Why?
| RNA, Small Interfering | 2 | 2016 | 581 | 0.060 |
Why?
| Gliosis | 1 | 2023 | 35 | 0.060 |
Why?
| Mitochondria, Liver | 1 | 2003 | 77 | 0.060 |
Why?
| Mitochondria, Heart | 1 | 2003 | 85 | 0.060 |
Why?
| Acetylcysteine | 1 | 2004 | 150 | 0.060 |
Why?
| Tyrosine | 1 | 2023 | 267 | 0.060 |
Why?
| Protein Tyrosine Phosphatases | 1 | 2023 | 162 | 0.060 |
Why?
| Necrosis | 3 | 2010 | 238 | 0.060 |
Why?
| Models, Cardiovascular | 1 | 2003 | 183 | 0.050 |
Why?
| Adenocarcinoma | 1 | 2009 | 837 | 0.050 |
Why?
| Rupture | 1 | 2022 | 107 | 0.050 |
Why?
| Wounds and Injuries | 1 | 2010 | 813 | 0.050 |
Why?
| Reperfusion | 1 | 2002 | 45 | 0.050 |
Why?
| Anterior Cruciate Ligament | 1 | 2022 | 91 | 0.050 |
Why?
| Oxaloacetic Acid | 1 | 2001 | 3 | 0.050 |
Why?
| Tumor Burden | 2 | 2014 | 277 | 0.050 |
Why?
| Middle Aged | 6 | 2016 | 28563 | 0.050 |
Why?
| Uric Acid | 1 | 2005 | 354 | 0.050 |
Why?
| AMP-Activated Protein Kinases | 2 | 2013 | 179 | 0.050 |
Why?
| Aspartic Acid | 1 | 2001 | 87 | 0.050 |
Why?
| Succinic Acid | 2 | 2013 | 47 | 0.050 |
Why?
| Teratoma | 1 | 2022 | 93 | 0.050 |
Why?
| Microsomes, Liver | 1 | 2001 | 59 | 0.050 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 432 | 0.050 |
Why?
| Tibia | 1 | 2022 | 182 | 0.050 |
Why?
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 71 | 0.050 |
Why?
| Random Allocation | 3 | 2006 | 360 | 0.050 |
Why?
| Drug Therapy, Combination | 3 | 2016 | 988 | 0.050 |
Why?
| gamma-Aminobutyric Acid | 1 | 2001 | 155 | 0.050 |
Why?
| Ligands | 2 | 2012 | 582 | 0.050 |
Why?
| Hematinics | 1 | 2019 | 18 | 0.050 |
Why?
| Astrocytoma | 1 | 2020 | 113 | 0.040 |
Why?
| Phenotype | 3 | 2016 | 3070 | 0.040 |
Why?
| Tunica Intima | 1 | 2000 | 79 | 0.040 |
Why?
| Brain Stem Neoplasms | 1 | 2020 | 90 | 0.040 |
Why?
| Heart Failure | 1 | 2013 | 2114 | 0.040 |
Why?
| Pregnancy Complications | 1 | 2004 | 462 | 0.040 |
Why?
| Sheep, Domestic | 1 | 2019 | 32 | 0.040 |
Why?
| Knee Joint | 1 | 2022 | 366 | 0.040 |
Why?
| Cell Movement | 2 | 2015 | 929 | 0.040 |
Why?
| Mice, SCID | 1 | 2019 | 339 | 0.040 |
Why?
| Fluorescent Antibody Technique | 2 | 2013 | 420 | 0.040 |
Why?
| Mouth Mucosa | 1 | 2019 | 81 | 0.040 |
Why?
| Radiology, Interventional | 1 | 2019 | 30 | 0.040 |
Why?
| Chromatography, Liquid | 1 | 2000 | 356 | 0.040 |
Why?
| Enzyme Activation | 2 | 2013 | 864 | 0.040 |
Why?
| Drug Administration Schedule | 2 | 2013 | 757 | 0.040 |
Why?
| Lysine | 1 | 2020 | 251 | 0.040 |
Why?
| Mifepristone | 1 | 2018 | 66 | 0.040 |
Why?
| Carcinoma, Adenoid Cystic | 1 | 2018 | 17 | 0.040 |
Why?
| Transplantation, Homologous | 1 | 2000 | 413 | 0.040 |
Why?
| Survival Analysis | 2 | 2016 | 1325 | 0.040 |
Why?
| Salivary Glands | 1 | 2018 | 32 | 0.040 |
Why?
| Breast | 1 | 2019 | 141 | 0.040 |
Why?
| Anthropometry | 1 | 2019 | 200 | 0.040 |
Why?
| Amino Acids | 1 | 2002 | 463 | 0.040 |
Why?
| Phantoms, Imaging | 1 | 2019 | 154 | 0.040 |
Why?
| NF-kappa B | 2 | 2013 | 676 | 0.040 |
Why?
| Citric Acid Cycle | 1 | 1997 | 45 | 0.040 |
Why?
| Lung Neoplasms | 1 | 2010 | 2216 | 0.040 |
Why?
| Cell Size | 1 | 1997 | 86 | 0.040 |
Why?
| Child | 3 | 2023 | 19561 | 0.040 |
Why?
| Weight Gain | 1 | 2001 | 511 | 0.040 |
Why?
| Immunohistochemistry | 2 | 2012 | 1727 | 0.040 |
Why?
| Digoxin | 1 | 2017 | 29 | 0.040 |
Why?
| Robotics | 1 | 2019 | 87 | 0.040 |
Why?
| Pentose Phosphate Pathway | 1 | 2017 | 44 | 0.040 |
Why?
| Aorta | 1 | 2000 | 368 | 0.040 |
Why?
| Cysteine | 1 | 2018 | 187 | 0.040 |
Why?
| Cytosol | 1 | 1997 | 229 | 0.040 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2010 | 70 | 0.040 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2019 | 229 | 0.040 |
Why?
| Nanomedicine | 1 | 2017 | 28 | 0.040 |
Why?
| Diet, High-Fat | 1 | 2018 | 248 | 0.040 |
Why?
| Benzothiazoles | 1 | 2016 | 37 | 0.040 |
Why?
| Hydrazines | 1 | 2016 | 32 | 0.040 |
Why?
| Rabbits | 1 | 2018 | 808 | 0.040 |
Why?
| Adventitia | 1 | 2016 | 39 | 0.040 |
Why?
| Lymph Nodes | 1 | 2019 | 466 | 0.040 |
Why?
| Heat Shock Transcription Factors | 2 | 2006 | 18 | 0.040 |
Why?
| Carbon | 1 | 2017 | 175 | 0.030 |
Why?
| Phenylurea Compounds | 1 | 2016 | 84 | 0.030 |
Why?
| Membrane Lipids | 1 | 1996 | 88 | 0.030 |
Why?
| Gestational Age | 1 | 2019 | 787 | 0.030 |
Why?
| Epigenesis, Genetic | 1 | 2020 | 551 | 0.030 |
Why?
| Fatty Acid Transport Proteins | 1 | 2015 | 19 | 0.030 |
Why?
| Epoxy Compounds | 1 | 2015 | 34 | 0.030 |
Why?
| Cell Hypoxia | 1 | 2016 | 229 | 0.030 |
Why?
| Stem Cell Niche | 1 | 2015 | 44 | 0.030 |
Why?
| Transforming Growth Factor beta | 1 | 2018 | 468 | 0.030 |
Why?
| Animals, Newborn | 1 | 1997 | 825 | 0.030 |
Why?
| Dihydrolipoyllysine-Residue Acetyltransferase | 1 | 2014 | 6 | 0.030 |
Why?
| Ketone Oxidoreductases | 1 | 2014 | 7 | 0.030 |
Why?
| Carnitine O-Palmitoyltransferase | 1 | 2015 | 48 | 0.030 |
Why?
| Sodium Hydroxide | 1 | 2014 | 8 | 0.030 |
Why?
| Risk Factors | 1 | 2009 | 9381 | 0.030 |
Why?
| Lipoprotein Lipase | 1 | 2015 | 69 | 0.030 |
Why?
| Neoplasm Recurrence, Local | 1 | 2020 | 903 | 0.030 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2014 | 59 | 0.030 |
Why?
| Precision Medicine | 1 | 2019 | 371 | 0.030 |
Why?
| Half-Life | 1 | 2014 | 147 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2015 | 322 | 0.030 |
Why?
| Recovery of Function | 1 | 2018 | 610 | 0.030 |
Why?
| Radiopharmaceuticals | 1 | 2015 | 196 | 0.030 |
Why?
| Bone Marrow | 1 | 2015 | 257 | 0.030 |
Why?
| Software | 1 | 2019 | 631 | 0.030 |
Why?
| Pyrroles | 1 | 2015 | 199 | 0.030 |
Why?
| Maze Learning | 1 | 2014 | 87 | 0.030 |
Why?
| Superoxides | 1 | 2014 | 225 | 0.030 |
Why?
| Neoplasm Invasiveness | 1 | 2015 | 472 | 0.030 |
Why?
| Tissue Donors | 2 | 2010 | 337 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2014 | 287 | 0.030 |
Why?
| Enzyme Induction | 1 | 2013 | 94 | 0.030 |
Why?
| Breeding | 1 | 2013 | 57 | 0.030 |
Why?
| beta-Galactosidase | 1 | 2013 | 67 | 0.030 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2014 | 198 | 0.030 |
Why?
| Mice, Inbred A | 1 | 2013 | 45 | 0.030 |
Why?
| Amino Acids, Aromatic | 1 | 2013 | 7 | 0.030 |
Why?
| Particle Size | 1 | 2014 | 344 | 0.030 |
Why?
| Antineoplastic Agents, Alkylating | 1 | 2013 | 70 | 0.030 |
Why?
| Catalysis | 1 | 2014 | 295 | 0.030 |
Why?
| Vacuoles | 1 | 2013 | 34 | 0.030 |
Why?
| Somatomedins | 1 | 2013 | 27 | 0.030 |
Why?
| Transcriptome | 1 | 2019 | 774 | 0.030 |
Why?
| Keratins | 1 | 2013 | 175 | 0.030 |
Why?
| Hyperplasia | 1 | 2013 | 169 | 0.030 |
Why?
| Staining and Labeling | 1 | 2013 | 159 | 0.030 |
Why?
| Cell Shape | 1 | 2013 | 55 | 0.030 |
Why?
| Mitogens | 1 | 2013 | 61 | 0.030 |
Why?
| Cell Differentiation | 1 | 2020 | 1805 | 0.030 |
Why?
| Glucose Transporter Type 4 | 1 | 2012 | 39 | 0.030 |
Why?
| Immunoenzyme Techniques | 1 | 2013 | 201 | 0.030 |
Why?
| Mitochondrial Proteins | 1 | 2014 | 231 | 0.030 |
Why?
| Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 82 | 0.030 |
Why?
| Adenoviridae | 1 | 2013 | 195 | 0.030 |
Why?
| RNA Interference | 1 | 2014 | 473 | 0.030 |
Why?
| Integrases | 1 | 2013 | 123 | 0.030 |
Why?
| Carcinogens | 1 | 2013 | 110 | 0.030 |
Why?
| Transplantation, Heterologous | 1 | 2013 | 194 | 0.030 |
Why?
| Neoplasm Grading | 1 | 2013 | 265 | 0.030 |
Why?
| Long-Term Potentiation | 1 | 2014 | 150 | 0.030 |
Why?
| RNA, Messenger | 2 | 2013 | 2720 | 0.030 |
Why?
| Epidermal Growth Factor | 1 | 2013 | 173 | 0.030 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 167 | 0.030 |
Why?
| Estradiol | 1 | 2015 | 477 | 0.030 |
Why?
| Molecular Chaperones | 1 | 2013 | 177 | 0.030 |
Why?
| RNA, Untranslated | 1 | 2013 | 116 | 0.030 |
Why?
| Mice, Inbred MRL lpr | 1 | 2011 | 40 | 0.030 |
Why?
| Colorado | 1 | 2022 | 4325 | 0.030 |
Why?
| Decision Making | 1 | 2019 | 840 | 0.030 |
Why?
| Gene Regulatory Networks | 1 | 2013 | 244 | 0.030 |
Why?
| Self Administration | 1 | 2012 | 125 | 0.030 |
Why?
| Sucrose | 1 | 2012 | 105 | 0.030 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2013 | 306 | 0.030 |
Why?
| Bortezomib | 1 | 2011 | 49 | 0.020 |
Why?
| beta Catenin | 1 | 2013 | 223 | 0.020 |
Why?
| Adenine | 1 | 2013 | 227 | 0.020 |
Why?
| Nestin | 1 | 2010 | 16 | 0.020 |
Why?
| Fatigue | 1 | 2013 | 311 | 0.020 |
Why?
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 204 | 0.020 |
Why?
| Urethane | 1 | 2010 | 40 | 0.020 |
Why?
| Kidney Glomerulus | 1 | 2011 | 133 | 0.020 |
Why?
| Intermediate Filament Proteins | 1 | 2010 | 70 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 783 | 0.020 |
Why?
| Protein Biosynthesis | 1 | 2013 | 408 | 0.020 |
Why?
| Receptors, Complement 3d | 1 | 2011 | 134 | 0.020 |
Why?
| Neutrophils | 2 | 2006 | 1246 | 0.020 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2011 | 140 | 0.020 |
Why?
| Mesenteric Arteries | 1 | 2010 | 16 | 0.020 |
Why?
| Immunoblotting | 1 | 2011 | 318 | 0.020 |
Why?
| HT29 Cells | 1 | 2010 | 37 | 0.020 |
Why?
| Kidney Function Tests | 1 | 2010 | 166 | 0.020 |
Why?
| Hydrogen | 1 | 2010 | 67 | 0.020 |
Why?
| Cluster Analysis | 1 | 2011 | 493 | 0.020 |
Why?
| Caspase 3 | 1 | 2011 | 246 | 0.020 |
Why?
| Limit of Detection | 1 | 2009 | 59 | 0.020 |
Why?
| Ki-67 Antigen | 1 | 2010 | 114 | 0.020 |
Why?
| Capillary Permeability | 1 | 2010 | 148 | 0.020 |
Why?
| Transplantation Conditioning | 1 | 2010 | 158 | 0.020 |
Why?
| Constriction, Pathologic | 1 | 2010 | 212 | 0.020 |
Why?
| Portal Vein | 1 | 2010 | 95 | 0.020 |
Why?
| Hippocampus | 1 | 2014 | 747 | 0.020 |
Why?
| Aged, 80 and over | 2 | 2013 | 6845 | 0.020 |
Why?
| Citrates | 1 | 2009 | 48 | 0.020 |
Why?
| Gene Deletion | 1 | 2010 | 365 | 0.020 |
Why?
| Celecoxib | 1 | 2008 | 39 | 0.020 |
Why?
| STAT3 Transcription Factor | 1 | 2010 | 193 | 0.020 |
Why?
| Capecitabine | 1 | 2008 | 46 | 0.020 |
Why?
| Free Radicals | 1 | 2009 | 100 | 0.020 |
Why?
| Infusions, Intravenous | 1 | 2010 | 396 | 0.020 |
Why?
| Cell Cycle | 1 | 2011 | 584 | 0.020 |
Why?
| Dura Mater | 1 | 2008 | 29 | 0.020 |
Why?
| Mammary Tumor Virus, Mouse | 1 | 2008 | 41 | 0.020 |
Why?
| Principal Component Analysis | 1 | 2009 | 186 | 0.020 |
Why?
| Mammary Neoplasms, Animal | 1 | 2008 | 29 | 0.020 |
Why?
| Craniotomy | 1 | 2008 | 69 | 0.020 |
Why?
| Bronchoscopy | 2 | 2000 | 254 | 0.020 |
Why?
| Down-Regulation | 1 | 2010 | 654 | 0.020 |
Why?
| Genotype | 1 | 2013 | 1943 | 0.020 |
Why?
| Drug Discovery | 1 | 2009 | 128 | 0.020 |
Why?
| Pressure | 1 | 2008 | 248 | 0.020 |
Why?
| Hypoglycemic Agents | 1 | 2015 | 1055 | 0.020 |
Why?
| Ethanol | 1 | 2012 | 584 | 0.020 |
Why?
| Transcription, Genetic | 1 | 2013 | 1355 | 0.020 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2010 | 537 | 0.020 |
Why?
| Nerve Tissue Proteins | 1 | 2010 | 557 | 0.020 |
Why?
| Carcinoma | 1 | 2008 | 212 | 0.020 |
Why?
| Child, Preschool | 1 | 2020 | 9755 | 0.020 |
Why?
| Peroxidase | 1 | 2006 | 182 | 0.020 |
Why?
| Aspartate Aminotransferases | 1 | 2006 | 96 | 0.020 |
Why?
| Alanine Transaminase | 1 | 2006 | 152 | 0.020 |
Why?
| Risk | 1 | 2008 | 890 | 0.020 |
Why?
| Intensive Care Units | 1 | 2010 | 664 | 0.020 |
Why?
| Membrane Transport Proteins | 1 | 2006 | 137 | 0.020 |
Why?
| Pilot Projects | 1 | 2010 | 1477 | 0.020 |
Why?
| Organ Size | 1 | 2006 | 474 | 0.020 |
Why?
| HSP27 Heat-Shock Proteins | 1 | 2005 | 14 | 0.020 |
Why?
| Antibodies, Monoclonal, Humanized | 1 | 2010 | 658 | 0.020 |
Why?
| Case-Control Studies | 1 | 2013 | 3296 | 0.020 |
Why?
| Intestinal Mucosa | 1 | 2010 | 543 | 0.020 |
Why?
| Quercetin | 1 | 2005 | 14 | 0.020 |
Why?
| Cytokines | 1 | 2013 | 1928 | 0.020 |
Why?
| Cerebral Cortex | 1 | 2008 | 430 | 0.020 |
Why?
| Computational Biology | 1 | 2009 | 601 | 0.020 |
Why?
| Dietary Fats | 1 | 2006 | 325 | 0.020 |
Why?
| Transplantation, Isogeneic | 1 | 2003 | 17 | 0.020 |
Why?
| Raffinose | 1 | 2003 | 19 | 0.020 |
Why?
| Organ Preservation Solutions | 1 | 2003 | 44 | 0.010 |
Why?
| Allopurinol | 1 | 2003 | 84 | 0.010 |
Why?
| Transcriptional Activation | 1 | 2005 | 360 | 0.010 |
Why?
| Protein Binding | 1 | 2009 | 2010 | 0.010 |
Why?
| Cell Membrane | 1 | 2006 | 741 | 0.010 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2004 | 240 | 0.010 |
Why?
| Adenosine | 1 | 2003 | 212 | 0.010 |
Why?
| Preoperative Care | 1 | 2004 | 342 | 0.010 |
Why?
| Trans-Activators | 1 | 2004 | 382 | 0.010 |
Why?
| Lipopolysaccharides | 1 | 2005 | 875 | 0.010 |
Why?
| Gene Expression | 1 | 2006 | 1506 | 0.010 |
Why?
| Automation | 1 | 2000 | 79 | 0.010 |
Why?
| Microchemistry | 1 | 2000 | 15 | 0.010 |
Why?
| Calibration | 1 | 2000 | 140 | 0.010 |
Why?
| Receptors, Interleukin-2 | 1 | 2000 | 73 | 0.010 |
Why?
| Autopsy | 1 | 2000 | 89 | 0.010 |
Why?
| Emulsions | 1 | 2000 | 46 | 0.010 |
Why?
| Blood | 1 | 2000 | 100 | 0.010 |
Why?
| Postoperative Period | 1 | 2000 | 317 | 0.010 |
Why?
| Prospective Studies | 1 | 2010 | 6704 | 0.010 |
Why?
| Chronic Disease | 1 | 2004 | 1645 | 0.010 |
Why?
| Immune Tolerance | 1 | 2000 | 355 | 0.010 |
Why?
| Regression Analysis | 1 | 2000 | 1018 | 0.010 |
Why?
| Recombinant Fusion Proteins | 1 | 2000 | 661 | 0.010 |
Why?
| Biopsy | 1 | 2000 | 1090 | 0.010 |
Why?
| Sensitivity and Specificity | 1 | 2000 | 1855 | 0.010 |
Why?
|
|
Serkova's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|